ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makowski, G. S
Right arrow Articles by Hopfer, S. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makowski, G. S
Right arrow Articles by Hopfer, S. M
Annals of Clinical & Laboratory Science 33:243-250 (2003)
© 2003 Association of Clinical Scientists

Single Tube Multiplex PCR Detection of 27 Cystic Fibrosis Mutations and 4 Polymorphisms using Neonatal Blood Samples Collected on Guthrie Cards

Gregory S Makowski, Francesca L Nadeau and Sidney M Hopfer
Department of Laboratory Medicine, University of Connecticut Health Center, Farmington, Connecticut

Address correspondence to: Gregory S. Makowski, Ph.D., Department of Laboratory Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030-2235, USA; tel: 860 679 2596; fax: 860 679 2154; e-mail: makowski{at}nso1.uchc.edu.

In response to recommendations for cystic fibrosis (CF) carrier screening of the American College of Medical Genetics/American College of Obstetrics and Gynecology (ACMG/ACOG), we evaluated a commercial kit for mutation panel testing (Roche CF Gold Linear Array Panel). This kit tests for 25 CF mutations and 4 polymorphisms; it comprises an analyte specific reagent for single tube multiplex polymerase chain reaction (PCR) amplification and subsequent allele specific oligonucleotide (ASO) hybridization. Neonatal whole blood samples collected on Guthrie card filter paper served as the DNA source. Following a wash step to remove whole blood PCR inhibitors, multiplex PCR amplification could be performed either on DNA that was heat extracted from Guthrie cards or directly on the filter paper matrix itself. In 13 CF patient samples, the CF mutation results obtained with this kit agreed completely with those obtained from a reference laboratory that performs an 87 CF mutation panel. The kit was reliable, despite the small sample size (3 mm diameter punch of the Guthrie card), the presence of PCR inhibitors in whole blood, and protracted storage of blood samples (up to 9 yr at room temperature). The kit was convenient, cost competitive, and practical for use in a small CF screening laboratory.

Keywords: multiplex PCR, cystic fibrosis, mutation analysis




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
M. Jarvis, R. K. Iyer, L. O. Williams, W. W. Noll, K. Thomas, M. Telatar, and W. W. Grody
A Novel Method for Creating Artificial Mutant Samples for Performance Evaluation and Quality Control in Clinical Molecular Genetics
J. Mol. Diagn., May 1, 2005; 7(2): 247 - 251.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association of Clinical Scientists.